Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Caris Life Sciences, Inc. | 2,574,533 | reported | 15 May 2026 | tx 3+320,112−182,668 |
| ADVANCEPCS | 1,081,278 | reported | 08 Mar 2004 | tx 20+2,094,452−2,944,452 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | TAX_WITHHOLDING | Caris Life Sciences, Inc. | 40,712 | 15.25 USD | |
| 06 Mar 2026 | GRANT_AWARD | Caris Life Sciences, Inc. | 320,112 | 0.00 USD | |
| 11 Aug 2025 | TAX_WITHHOLDING | Caris Life Sciences, Inc. | 141,956 | 29.75 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 5,556 | 2.25 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 26,842 | 3.13 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 272,766 | 7.34 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 229,288 | 9.34 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 850,000 | 10.00 USD | |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 650,000 | 10.00 USD | |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 60,000 | 28.65 USD | |
| 05 Mar 2004 | SALE | ADVANCEPCS | 5,556 | 71.82 USD | |
| 05 Mar 2004 | SALE | ADVANCEPCS | 26,842 | 71.95 USD | |
| 05 Mar 2004 | SALE | ADVANCEPCS | 272,766 | 72.13 USD | |
| 05 Mar 2004 | SALE | ADVANCEPCS | 176,186 | 71.77 USD | |
| 08 Mar 2004 | SALE | ADVANCEPCS | 53,102 | 71.83 USD | |
| 08 Mar 2004 | SALE | ADVANCEPCS | 315,548 | 72.14 USD | |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 5,556 | 0.00 USD | deriv |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 26,842 | 0.00 USD | deriv |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 272,766 | 0.00 USD | deriv |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 229,288 | 0.00 USD | deriv |
| 05 Mar 2004 | EXERCISE | ADVANCEPCS | 850,000 | 0.00 USD | deriv |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 650,000 | 0.00 USD | deriv |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 60,000 | 0.00 USD | deriv |